{"date":"2025-08-27","count":13,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2025-08-27-2025-1jewwcn","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-08-27","time":"20:25:19","subject":"代重要子公司Belite Bio, Inc公告受邀參加H.C. Wainwright &Co.投資銀行舉辦之第27屆全球投資年會(H.C. Wainwright 27thAnnual Global Investment Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-08-27 20:25，「代重要子公司Belite Bio, Inc公告受邀參加H.C. Wainwright &Co.投資銀行舉辦之第27屆全球」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-08-27-2022-3ae9bq","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-08-27","time":"20:22:16","subject":"代重要子公司Belite Bio, Inc公告受邀參加Morgan Stanley投資銀行舉辦之第23屆全球醫療年會(Morgan Stanley 23rdAnnual Global Healthcare Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-08-27 20:22，「代重要子公司Belite Bio, Inc公告受邀參加Morgan Stanley投資銀行舉辦之第23屆全球醫療年會(M」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-08-27-2013-flq0cw","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-08-27","time":"20:13:57","subject":"代重要子公司Belite Bio, Inc公告受邀參加Cantor Fitzgerald投資銀行舉辦之全球醫療論壇(Global Healthcare Conference)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-08-27 20:13，「代重要子公司Belite Bio, Inc公告受邀參加Cantor Fitzgerald投資銀行舉辦之全球醫療論壇(Gl」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2025-08-27-1751-1bi2fou","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2025-08-27","time":"17:51:40","subject":"本公司受邀參加台新證券舉辦之法人說明會","clause":"第30款","fact_date":"2025-09-15","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2025-08-27 17:51，「本公司受邀參加台新證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2025-08-27-1646-1s85xjh","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-27","time":"16:46:30","subject":"本公司檢測試劑DNlite-DKD uPTM-FetA ELISA Kit獲得科威特主管機關核發上巿許可","clause":"第44款","fact_date":"2025-08-27","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2025-08-27 16:46，「本公司檢測試劑DNlite-DKD uPTM-FetA ELISA Kit獲得科威特主管機關核發上巿許可」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6808-2025-08-27-1626-gi3647","company_id":"6808","company":"三鼎生技","market":"興櫃","industry":"生技醫療","date":"2025-08-27","time":"16:26:37","subject":"公告本公司董事會決議買回庫藏股事宜","clause":"第41款","fact_date":"2025-08-27","cite_as":"公開資訊觀測站重大訊息：三鼎生技（6808），2025-08-27 16:26，「公告本公司董事會決議買回庫藏股事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-08-27-1621-18bhctm","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-08-27","time":"16:21:28","subject":"公告本公司初次上櫃掛牌首五個營業日穩定價格操作結果","clause":"第53款","fact_date":"2025-08-27","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-08-27 16:21，「公告本公司初次上櫃掛牌首五個營業日穩定價格操作結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2025-08-27-1609-1kstx57","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-27","time":"16:09:17","subject":"本公司訂定114年現金增資認股基準日暨相關事宜","clause":"第9款","fact_date":"2025-08-27","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2025-08-27 16:09，「本公司訂定114年現金增資認股基準日暨相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1760-2025-08-27-1554-1ac8xga","company_id":"1760","company":"寶齡富錦","market":"上市","industry":"生技醫療","date":"2025-08-27","time":"15:54:41","subject":"本公司提交PBF-1681 Tablet新劑型暨新適應症之新藥查驗登記(NDA)申請","clause":"第10款","fact_date":"2025-08-27","cite_as":"公開資訊觀測站重大訊息：寶齡富錦（1760），2025-08-27 15:54，「本公司提交PBF-1681 Tablet新劑型暨新適應症之新藥查驗登記(NDA)申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2025-08-27-1520-1twpcjc","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2025-08-27","time":"15:20:50","subject":"公告本公司國內第四次有擔保轉換公司債代收價款行庫及存儲專戶行庫","clause":"第53款","fact_date":"2025-08-27","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2025-08-27 15:20，「公告本公司國內第四次有擔保轉換公司債代收價款行庫及存儲專戶行庫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2025-08-27-1512-1s56t5d","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2025-08-27","time":"15:12:14","subject":"公告本公司受邀參加元大證券舉辦之投資論壇","clause":"第12款","fact_date":"2025-09-03","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2025-08-27 15:12，「公告本公司受邀參加元大證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-08-27-0937-p3ap4l","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-08-27","time":"09:37:55","subject":"更正本公司114年5-7月衍生性商品申報交易資訊","clause":"第53款","fact_date":"2025-08-27","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-08-27 09:37，「更正本公司114年5-7月衍生性商品申報交易資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-08-27-0916-1lmv9jb","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-08-27","time":"09:16:04","subject":"公告補正本公司113年度股東會年報部分內容","clause":"第50款","fact_date":"2025-08-27","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-08-27 09:16，「公告補正本公司113年度股東會年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}